Loading...
Header Logo
Keywords
Last Name
Institution

WAYNE K. GOODMAN

TitleChair
InstitutionBaylor College of Medicine
DepartmentDepartment of Psychiatry & Behavioral Sciences
DivisionPsychiatry & Behavioral Sciences
AddressDepartment of Psychiatry
One Baylor Plaza, BCM 350
Houston TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Psychiatry & Behavioral Sciences
    DivisionPsychiatry & Behavioral Sciences


    Collapse Research 
    Collapse research activities and funding
    R01MH045802     (GOODMAN, WAYNE K)Sep 15, 1992 - Apr 30, 2001
    NIH/NIMH
    NEUROBIOLOGY AND TREATMENT OF OCD
    Role: Principal Investigator

    R01MH056597     (GOODMAN, WAYNE K)Mar 1, 1997 - Feb 28, 2001
    NIH/NIMH
    ANTIGEN D8/17 AS A MARKER FOR CHILDHOOD ONSET OCD/TS
    Role: Principal Investigator

    R01MH063914     (MURPHY, TANYA K)Apr 26, 2002 - Mar 31, 2007
    NIH/NIMH
    Prospective Study of 'PANDAS'
    Role: Co-Principal Investigator

    R21MH064161     (WARD, HERBERT E)Aug 21, 2002 - Jun 30, 2009
    NIH/NIMH
    Pilot Study of DBS for Treatment-Refractory OCD
    Role: Co-Principal Investigator

    R01MH078594     (GOODMAN, WAYNE K)Aug 18, 2006 - May 31, 2010
    NIH/NIMH
    SSRI-Induced Activation Syndrome In Pediatric OCD
    Role: Principal Investigator

    UH3NS100549     (GOODMAN, WAYNE K)Sep 30, 2016 - Jun 30, 2022
    NIH/NINDS
    Adaptive DBS in Non-Motor Neuropsychiatric Disorders: Regulating Limbic Circuit Imbalance
    Role: Principal Investigator

    R01MH114854     (LAZARO-MUNOZ, GABRIEL)Sep 15, 2017 - Aug 31, 2021
    NIH/NIMH
    Neuroethics of aDBS Systems Targeting Neuropsychiatric and Movement Disorders
    Role: Co-Principal Investigator

    UH3NS103549     (SHETH, SAMEER ANIL)Sep 15, 2017 - Aug 31, 2022
    NIH/NINDS
    Deep brain stimulation for depression using directional current steering an individualized network targeting
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Davis ML, Fletcher T, McIngvale E, Cepeda SL, Schneider SC, La Buissonnière Ariza V, Egberts J, Goodman W, Storch EA. Clinicians' perspectives of interfering behaviors in the treatment of anxiety and obsessive-compulsive disorders in adults and children. Cogn Behav Ther. 2019 Mar 12; 1-16. PMID: 30862251.
      View in: PubMed
    2. Guzick AG, Cooke DL, McNamara JPH, Reid AM, Graziano PA, Lewin AB, Murphy TK, Goodman WK, Storch EA, Geffken GR. Parents' Perceptions of Internalizing and Externalizing Features in Childhood OCD. Child Psychiatry Hum Dev. 2019 Feb 18. PMID: 30778711.
      View in: PubMed
    3. Zhang CC, Gong H, Zhang Y, Jin H, Yang Y, Li B, Li Y, Luo X, Liu W, Fang F, Li B, Sun B, Fletcher T, La Buissonnière-Ariza V, Goodman WK, Storch EA. Development and psychometric evaluation of the Mandarin Chinese version of the Yale-Brown Obsessive-Compulsive Scale - Second Edition. Braz J Psychiatry. 2019 Feb 18. PMID: 30785537.
      View in: PubMed
    4. Karas PJ, Lee S, Jimenez-Shahed J, Goodman WK, Viswanathan A, Sheth SA. Deep Brain Stimulation for Obsessive Compulsive Disorder: Evolution of Surgical Stimulation Target Parallels Changing Model of Dysfunctional Brain Circuits. Front Neurosci. 2018; 12:998. PMID: 30670945.
      View in: PubMed
    5. Krystal AD, Pizzagalli DA, Mathew SJ, Sanacora G, Keefe R, Song A, Calabrese J, Goddard A, Goodman W, Lisanby SH, Smoski M, Weiner R, Iosifescu D, Nurnberger J, Szabo S, Murrough J, Shekhar A, Potter W. The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development. Nat Rev Drug Discov. 2018 Dec 28; 18(1):82-84. PMID: 30591715.
      View in: PubMed
    6. Brown C, Shahab R, Collins K, Fleysher L, Goodman WK, Burdick KE, Stern ER. Functional neural mechanisms of sensory phenomena in obsessive-compulsive disorder. J Psychiatr Res. 2019 Feb; 109:68-75. PMID: 30508745.
      View in: PubMed
    7. Storch EA, McGuire JF, Wu MS, Hamblin R, McIngvale E, Cepeda SL, Schneider SC, Rufino KA, Rasmussen SA, Price LH, Goodman WK. Development and Psychometric Evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale Second Edition. J Am Acad Child Adolesc Psychiatry. 2019 Jan; 58(1):92-98. PMID: 30577944.
      View in: PubMed
    8. Cohn JF, Okun MS, Jeni LA, Ertugrul IO, Borton D, Malone D, Goodman WK. Automated Affect Detection in Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Pilot Study. Proc ACM Int Conf Multimodal Interact. 2018 Oct; 2018:40-44. PMID: 30511050.
      View in: PubMed
    9. Hildebrandt T, Schulz K, Schiller D, Heywood A, Goodman W, Sysko R. Evidence of prefrontal hyperactivation to food-cue reversal learning in adolescents with anorexia nervosa. Behav Res Ther. 2018 Dec; 111:36-43. PMID: 30292918.
      View in: PubMed
    10. Gosnell SN, Curtis KN, Velasquez K, Fowler JC, Madan A, Goodman W, Salas R. Habenular connectivity may predict treatment response in depressed psychiatric inpatients. J Affect Disord. 2019 01 01; 242:211-219. PMID: 30195174.
      View in: PubMed
    11. Stern ER, Shahab R, Grimaldi SJ, Leibu E, Murrough JW, Fleysher L, Parides MK, Coffey BJ, Burdick KE, Goodman WK. High-dose ondansetron reduces activation of interoceptive and sensorimotor brain regions. Neuropsychopharmacology. 2019 01; 44(2):390-398. PMID: 30116006.
      View in: PubMed
    12. Banneyer KN, Bonin L, Price K, Goodman WK, Storch EA. Cognitive Behavioral Therapy for Childhood Anxiety Disorders: a Review of Recent Advances. Curr Psychiatry Rep. 2018 Jul 28; 20(8):65. PMID: 30056623.
      View in: PubMed
    13. Lázaro-Muñoz G, Yoshor D, Beauchamp MS, Goodman WK, McGuire AL. Continued access to investigational brain implants. Nat Rev Neurosci. 2018 Jun; 19(6):317-318. PMID: 29686310.
      View in: PubMed
    14. Cepeda SL, McKay D, Schneider SC, La Buissonnière-Ariza V, Egberts JTNE, McIngvale E, Goodman WK, Storch EA. Politically-focused intrusive thoughts and associated ritualistic behaviors in a community sample. J Anxiety Disord. 2018 May; 56:35-42. PMID: 29631796.
      View in: PubMed
    15. Davis ML, McCann M, Goodman WK, Storch EA. Impact of the 2016 US presidential election on OCD symptom presentation: A case illustration. J Clin Psychol. 2018 May; 74(5):750-754. PMID: 29528496.
      View in: PubMed
    16. Bari AA, Mikell CB, Abosch A, Ben-Haim S, Buchanan RJ, Burton AW, Carcieri S, Cosgrove GR, D'Haese PF, Daskalakis ZJ, Eskandar EN, Gerrard JL, Goodman WK, Greenberg BD, Gross RE, Hamani C, Kiss ZHT, Konrad P, Kopell BH, Krinke L, Langevin JP, Lozano AM, Malone D, Mayberg HS, Miller JP, Patil PG, Peichel D, Petersen EA, Rezai AR, Richardson RM, Riva-Posse P, Sankar T, Schwalb JM, Simpson HB, Slavin K, Stypulkowski PH, Tosteson T, Warnke P, Willie JT, Zaghloul KA, Neimat JS, Pouratian N, Sheth SA. Charting the road forward in psychiatric neurosurgery: proceedings of the 2016 American Society for Stereotactic and Functional Neurosurgery workshop on neuromodulation for psychiatric disorders. J Neurol Neurosurg Psychiatry. 2018 Aug; 89(8):886-896. PMID: 29371415.
      View in: PubMed
    17. Ramirez-Zamora A, Giordano JJ, Gunduz A, Brown P, Sanchez JC, Foote KD, Almeida L, Starr PA, Bronte-Stewart HM, Hu W, McIntyre C, Goodman W, Kumsa D, Grill WM, Walker HC, Johnson MD, Vitek JL, Greene D, Rizzuto DS, Song D, Berger TW, Hampson RE, Deadwyler SA, Hochberg LR, Schiff ND, Stypulkowski P, Worrell G, Tiruvadi V, Mayberg HS, Jimenez-Shahed J, Nanda P, Sheth SA, Gross RE, Lempka SF, Li L, Deeb W, Okun MS. Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think Tank. Front Neurosci. 2017; 11:734. PMID: 29416498.
      View in: PubMed
    18. Shah AA, Valles N, Banu S, Storch EA, Goodman W. Meeting the Mental Health Needs of Hurricane Harvey Evacuees. Am J Psychiatry. 2018 Jan 01; 175(1):13-14. PMID: 29301425.
      View in: PubMed
    19. Stern ER, Grimaldi SJ, Muratore A, Murrough J, Leibu E, Fleysher L, Goodman WK, Burdick KE. Neural correlates of interoception: Effects of interoceptive focus and relationship to dimensional measures of body awareness. Hum Brain Mapp. 2017 12; 38(12):6068-6082. PMID: 28901713.
      View in: PubMed
    20. Rasgon A, Lee WH, Leibu E, Laird A, Glahn D, Goodman W, Frangou S. Neural correlates of affective and non-affective cognition in obsessive compulsive disorder: A meta-analysis of functional imaging studies. Eur Psychiatry. 2017 10; 46:25-32. PMID: 28992533.
      View in: PubMed
    21. Lázaro-Muñoz G, McGuire AL, Goodman WK. Should we be concerned about preserving agency and personal identity in patients with Adaptive Deep Brain Stimulation systems? AJOB Neurosci. 2017; 8(2):73-75. PMID: 29238625.
      View in: PubMed
    22. Mataix-Cols D, Fernández de la Cruz L, Monzani B, Rosenfield D, Andersson E, Pérez-Vigil A, Frumento P, de Kleine RA, Difede J, Dunlop BW, Farrell LJ, Geller D, Gerardi M, Guastella AJ, Hofmann SG, Hendriks GJ, Kushner MG, Lee FS, Lenze EJ, Levinson CA, McConnell H, Otto MW, Plag J, Pollack MH, Ressler KJ, Rodebaugh TL, Rothbaum BO, Scheeringa MS, Siewert-Siegmund A, Smits JAJ, Storch EA, Ströhle A, Tart CD, Tolin DF, van Minnen A, Waters AM, Weems CF, Wilhelm S, Wyka K, Davis M, Rück C, Altemus M, Anderson P, Cukor J, Finck C, Geffken GR, Golfels F, Goodman WK, Gutner C, Heyman I, Jovanovic T, Lewin AB, McNamara JP, Murphy TK, Norrholm S, Thuras P. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data. JAMA Psychiatry. 2017 05 01; 74(5):501-510. PMID: 28122091.
      View in: PubMed
    23. Fayad SM, Guzick AG, Reid AM, Mason DM, Bertone A, Foote KD, Okun MS, Goodman WK, Ward HE. Six-Nine Year Follow-Up of Deep Brain Stimulation for Obsessive-Compulsive Disorder. PLoS One. 2016; 11(12):e0167875. PMID: 27930748.
      View in: PubMed
    24. Guzick AG, McNamara JPH, Reid AM, Balkhi AM, Storch EA, Murphy TK, Goodman WK, Bussing R, Geffken GR. The link between ADHD-like inattention and obsessions and compulsions during treatment of youth with OCD. J Obsessive Compuls Relat Disord. 2017 Jan; 12:1-8. PMID: 28966908.
      View in: PubMed
    25. Stern ER, Muratore AF, Taylor SF, Abelson JL, Hof PR, Goodman WK. Switching between internally and externally focused attention in obsessive-compulsive disorder: Abnormal visual cortex activation and connectivity. Psychiatry Res Neuroimaging. 2017 Jul 30; 265:87-97. PMID: 28024845.
      View in: PubMed
    26. Rosenthal DL, Leibu E, Aloysi AS, Kopell BH, Goodman WK, Kellner CH. Safety and efficacy of electroconvulsive therapy for depression in the presence of deep brain stimulation in obsessive-compulsive disorder. J Clin Psychiatry. 2016 05; 77(5):689-90. PMID: 27249078.
      View in: PubMed
    27. O'Halloran R, Kopell BH, Sprooten E, Goodman WK, Frangou S. Multimodal Neuroimaging-Informed Clinical Applications in Neuropsychiatric Disorders. Front Psychiatry. 2016; 7:63. PMID: 27148092.
      View in: PubMed
    28. Rossi PJ, Gunduz A, Judy J, Wilson L, Machado A, Giordano JJ, Elias WJ, Rossi MA, Butson CL, Fox MD, McIntyre CC, Pouratian N, Swann NC, de Hemptinne C, Gross RE, Chizeck HJ, Tagliati M, Lozano AM, Goodman W, Langevin JP, Alterman RL, Akbar U, Gerhardt GA, Grill WM, Hallett M, Herrington T, Herron J, van Horne C, Kopell BH, Lang AE, Lungu C, Martinez-Ramirez D, Mogilner AY, Molina R, Opri E, Otto KJ, Oweiss KG, Pathak Y, Shukla A, Shute J, Sheth SA, Shih LC, Steinke GK, Tröster AI, Vanegas N, Zaghloul KA, Cendejas-Zaragoza L, Verhagen L, Foote KD, Okun MS. Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies. Front Neurosci. 2016; 10:119. PMID: 27092042; PMCID: PMC4821860.
    29. Ely BA, Xu J, Goodman WK, Lapidus KA, Gabbay V, Stern ER. Resting-state functional connectivity of the human habenula in healthy individuals: Associations with subclinical depression. Hum Brain Mapp. 2016 07; 37(7):2369-84. PMID: 26991474.
      View in: PubMed
    30. Kim JW, Naidich TP, Ely BA, Yacoub E, De Martino F, Fowkes ME, Goodman WK, Xu J. Human habenula segmentation using myelin content. Neuroimage. 2016 Apr 15; 130:145-156. PMID: 26826517.
      View in: PubMed
    31. Hartmann CJ, Lujan JL, Chaturvedi A, Goodman WK, Okun MS, McIntyre CC, Haq IU. Tractography Activation Patterns in Dorsolateral Prefrontal Cortex Suggest Better Clinical Responses in OCD DBS. Front Neurosci. 2015; 9:519. PMID: 26834544; PMCID: PMC4717315.
    32. Reid AM, McNamara JP, Murphy TK, Guzick AG, Storch EA, Goodman WK, Geffken GR, Bussing R. Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial. J Psychiatr Res. 2015 Dec; 71:140-7. PMID: 26495770; PMCID: PMC4653063 [Available on 12/01/16].
    33. Berlin HA, Schulz KP, Zhang S, Turetzky R, Rosenthal D, Goodman W. Neural correlates of emotional response inhibition in obsessive-compulsive disorder: A preliminary study. Psychiatry Res. 2015 Nov 30; 234(2):259-64. PMID: 26456416.
      View in: PubMed
    34. Murrough JW, Soleimani L, DeWilde KE, Collins KA, Lapidus KA, Iacoviello BM, Lener M, Kautz M, Kim J, Stern JB, Price RB, Perez AM, Brallier JW, Rodriguez GJ, Goodman WK, Iosifescu DV, Charney DS. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Psychol Med. 2015 Dec; 45(16):3571-80. PMID: 26266877.
      View in: PubMed
    35. Alonso P, Cuadras D, Gabriëls L, Denys D, Goodman W, Greenberg BD, Jimenez-Ponce F, Kuhn J, Lenartz D, Mallet L, Nuttin B, Real E, Segalas C, Schuurman R, du Montcel ST, Menchon JM. Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Meta-Analysis of Treatment Outcome and Predictors of Response. PLoS One. 2015; 10(7):e0133591. PMID: 26208305.
      View in: PubMed
    36. Hildebrandt T, Grotzinger A, Reddan M, Greif R, Levy I, Goodman W, Schiller D. Testing the disgust conditioning theory of food-avoidance in adolescents with recent onset anorexia nervosa. Behav Res Ther. 2015 Aug; 71:131-8. PMID: 26131915.
      View in: PubMed
    37. Gunduz A, Morita H, Rossi PJ, Allen WL, Alterman RL, Bronte-Stewart H, Butson CR, Charles D, Deckers S, de Hemptinne C, DeLong M, Dougherty D, Ellrich J, Foote KD, Giordano J, Goodman W, Greenberg BD, Greene D, Gross R, Judy JW, Karst E, Kent A, Kopell B, Lang A, Lozano A, Lungu C, Lyons KE, Machado A, Martens H, McIntyre C, Min HK, Neimat J, Ostrem J, Pannu S, Ponce F, Pouratian N, Reymers D, Schrock L, Sheth S, Shih L, Stanslaski S, Steinke GK, Stypulkowski P, Tröster AI, Verhagen L, Walker H, Okun MS. Proceedings of the Second Annual Deep Brain Stimulation Think Tank: What's in the Pipeline. Int J Neurosci. 2015; 125(7):475-85. PMID: 25526555.
      View in: PubMed
    38. Goodman WK, Grice DE, Lapidus KA, Coffey BJ. Obsessive-compulsive disorder. Psychiatr Clin North Am. 2014 Sep; 37(3):257-67. PMID: 25150561.
      View in: PubMed
    39. Goodman WK. Obsessive compulsive and related disorders. Psychiatr Clin North Am. 2014 Sep; 37(3):xi-xii. PMID: 25150571.
      View in: PubMed
    40. Lapidus KA, Stern ER, Berlin HA, Goodman WK. Neuromodulation for obsessive-compulsive disorder. Neurotherapeutics. 2014 Jul; 11(3):485-95. PMID: 24981434; PMCID: PMC4121444.
    41. Stern ER, Muratore AF, Taylor SF, Abelson JL, Hof PR, Goodman WK. The Persistence of Experience: Prior Attentional and Emotional State Affects Network Functioning in a Target Detection Task. Cereb Cortex. 2015 Sep; 25(9):3235-48. PMID: 24904075; PMCID: PMC4537450.
    42. Mirrione MM, Schulz D, Lapidus KA, Zhang S, Goodman W, Henn FA. Increased metabolic activity in the septum and habenula during stress is linked to subsequent expression of learned helplessness behavior. Front Hum Neurosci. 2014; 8:29. PMID: 24550809; PMCID: PMC3909949.
    43. Garnaat SL, Greenberg BD, Sibrava NJ, Goodman WK, Mancebo MC, Eisen JL, Rasmussen SA. Who qualifies for deep brain stimulation for OCD? Data from a naturalistic clinical sample. J Neuropsychiatry Clin Neurosci. 2014; 26(1):81-6. PMID: 24515679; PMCID: PMC4093791.
    44. Morishita T, Fayad SM, Goodman WK, Foote KD, Chen D, Peace DA, Rhoton AL, Okun MS. Surgical neuroanatomy and programming in deep brain stimulation for obsessive compulsive disorder. Neuromodulation. 2014 Jun; 17(4):312-9; discussion 319. PMID: 24345303; PMCID: PMC4061279.
    45. Storch EA, Bussing R, Small BJ, Geffken GR, McNamara JP, Rahman O, Lewin AB, Garvan CS, Goodman WK, Murphy TK. Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder. Behav Res Ther. 2013 Dec; 51(12):823-9. PMID: 24184429; PMCID: PMC3908957.
    46. Hogendoorn SM, de Haan E, Wolters LH, Vervoort L, Prins PJ, de Bourgraaf A, Scheerman NA, Nauta MH, Hartman CA, Boer F, Goodman WK. The anxiety severity interview for children and adolescents: an individualized repeated measure of anxiety severity. Clin Psychol Psychother. 2014 Nov-Dec; 21(6):525-35. PMID: 24000105.
      View in: PubMed
    47. Storch EA, Goddard AW, Grant JE, De Nadai AS, Goodman WK, Mutch PJ, Medlock C, Odlaug B, McDougle CJ, Murphy TK. Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder. J Clin Psychiatry. 2013 Jun; 74(6):e527-32. PMID: 23842022.
      View in: PubMed
    48. Bloch MH, Green C, Kichuk SA, Dombrowski PA, Wasylink S, Billingslea E, Landeros-Weisenberger A, Kelmendi B, Goodman WK, Leckman JF, Coric V, Pittenger C. Long-term outcome in adults with obsessive-compulsive disorder. Depress Anxiety. 2013 Aug; 30(8):716-22. PMID: 23532944; PMCID: PMC3932438.
    49. Lapidus KA, Kopell BH, Ben-Haim S, Rezai AR, Goodman WK. History of psychosurgery: a psychiatrist's perspective. World Neurosurg. 2013 Sep-Oct; 80(3-4):S27.e1-16. PMID: 23419707.
      View in: PubMed
    50. Okun MS, Foote KD, Wu SS, Ward HE, Bowers D, Rodriguez RL, Malaty IA, Goodman WK, Gilbert DM, Walker HC, Mink JW, Merritt S, Morishita T, Sanchez JC. A trial of scheduled deep brain stimulation for Tourette syndrome: moving away from continuous deep brain stimulation paradigms. JAMA Neurol. 2013 Jan; 70(1):85-94. PMID: 23044532.
      View in: PubMed
    51. Bussing R, Murphy TK, Storch EA, McNamara JP, Reid AM, Garvan CW, Goodman WK. Psychometric properties of the Treatment-Emergent Activation and Suicidality Assessment Profile (TEASAP) in youth with OCD. Psychiatry Res. 2013 Feb 28; 205(3):253-61. PMID: 23031804; PMCID: PMC3540123.
    52. Vora AK, Ward H, Foote KD, Goodman WK, Okun MS. Rebound symptoms following battery depletion in the NIH OCD DBS cohort: clinical and reimbursement issues. Brain Stimul. 2012 Oct; 5(4):599-604. PMID: 22305344.
      View in: PubMed
    53. Goodman WK, Alterman RL. Deep brain stimulation for intractable psychiatric disorders. Annu Rev Med. 2012; 63:511-24. PMID: 22034866.
      View in: PubMed
    54. Murphy TK, Storch EA, Lewin AB, Edge PJ, Goodman WK. Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Pediatr. 2012 Feb; 160(2):314-9. PMID: 21868033; PMCID: PMC3227761.
    55. Goodman WK. Electroconvulsive therapy in the spotlight. N Engl J Med. 2011 May 12; 364(19):1785-7. PMID: 21561344.
      View in: PubMed
    56. McGuire JF, Storch EA, Lewin AB, Price LH, Rasmussen SA, Goodman WK. The role of avoidance in the phenomenology of obsessive-compulsive disorder. Compr Psychiatry. 2012 Feb; 53(2):187-94. PMID: 21550030.
      View in: PubMed
    57. Storch EA, Murphy TK, Goodman WK, Geffken GR, Lewin AB, Henin A, Micco JA, Sprich S, Wilhelm S, Bengtson M, Geller DA. A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry. 2010 Dec 01; 68(11):1073-6. PMID: 20817153; PMCID: PMC3034091.
    58. Lewin AB, De Nadai AS, Park J, Goodman WK, Murphy TK, Storch EA. Refining clinical judgment of treatment outcome in obsessive-compulsive disorder. Psychiatry Res. 2011 Feb 28; 185(3):394-401. PMID: 20846725.
      View in: PubMed
    59. Haq IU, Foote KD, Goodman WK, Ricciuti N, Ward H, Sudhyadhom A, Jacobson CE, Siddiqui MS, Okun MS. A case of mania following deep brain stimulation for obsessive compulsive disorder. Stereotact Funct Neurosurg. 2010; 88(5):322-8. PMID: 20714212; PMCID: PMC2969111.
    60. Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, Alphs LD, Broich K, Goodman WK, Greden JF, Meltzer HY, Normand SL, Posner K, Shaffer D, Oquendo MA, Stanley B, Trivedi MH, Turecki G, Beasley CM, Beautrais AL, Bridge JA, Brown GK, Revicki DA, Ryan ND, Sheehan DV. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry. 2010 Aug; 71(8):e1-e21. PMID: 20797373.
      View in: PubMed
    61. Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, Alphs LD, Broich K, Goodman WK, Greden JF, Meltzer HY, Normand SL, Posner K, Shaffer D, Oquendo MA, Stanley B, Trivedi MH, Turecki G, Beasley CM, Beautrais AL, Bridge JA, Brown GK, Revicki DA, Ryan ND, Sheehan DV. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report. J Clin Psychiatry. 2010 Aug; 71(8):1040-6. PMID: 20673551.
      View in: PubMed
    62. Triggs WJ, Ricciuti N, Ward HE, Cheng J, Bowers D, Goodman WK, Kluger BM, Nadeau SE. Right and left dorsolateral pre-frontal rTMS treatment of refractory depression: a randomized, sham-controlled trial. Psychiatry Res. 2010 Aug 15; 178(3):467-74. PMID: 20643486.
      View in: PubMed
    63. Storch EA, Rasmussen SA, Price LH, Larson MJ, Murphy TK, Goodman WK. Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale--Second Edition. Psychol Assess. 2010 Jun; 22(2):223-32. PMID: 20528050.
      View in: PubMed
    64. Leckman JF, Denys D, Simpson HB, Mataix-Cols D, Hollander E, Saxena S, Miguel EC, Rauch SL, Goodman WK, Phillips KA, Stein DJ. Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depress Anxiety. 2010 Jun; 27(6):507-27. PMID: 20217853; PMCID: PMC3974619.
    65. Storch EA, Larson MJ, Price LH, Rasmussen SA, Murphy TK, Goodman WK. Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist. J Anxiety Disord. 2010 Aug; 24(6):650-6. PMID: 20471199.
      View in: PubMed
    66. Burdick A, Foote KD, Goodman W, Ward HE, Ricciuti N, Murphy T, Haq I, Okun MS. Lack of benefit of accumbens/capsular deep brain stimulation in a patient with both tics and obsessive-compulsive disorder. Neurocase. 2010 Aug; 16(4):321-30. PMID: 20178034.
      View in: PubMed
    67. Goodman WK, Foote KD, Greenberg BD, Ricciuti N, Bauer R, Ward H, Shapira NA, Wu SS, Hill CL, Rasmussen SA, Okun MS. Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggered-onset design. Biol Psychiatry. 2010 Mar 15; 67(6):535-42. PMID: 20116047.
      View in: PubMed
    68. Reid JM, Storch EA, Murphy TK, Bodzin D, Mutch PJ, Lehmkuhl H, Aman M, Goodman WK. Development and Psychometric Evaluation of the Treatment-Emergent Activation and Suicidality Assessment Profile. Child Youth Care Forum. 2010 Feb 04; 39(2):113-124. PMID: 20473344.
      View in: PubMed
    69. Merlo LJ, Storch EA, Lehmkuhl HD, Jacob ML, Murphy TK, Goodman WK, Geffken GR. Cognitive behavioral therapy plus motivational interviewing improves outcome for pediatric obsessive-compulsive disorder: a preliminary study. Cogn Behav Ther. 2010; 39(1):24-7. PMID: 19675960; PMCID: PMC2861340.
    70. Landeros-Weisenberger A, Bloch MH, Kelmendi B, Wegner R, Nudel J, Dombrowski P, Pittenger C, Krystal JH, Goodman WK, Leckman JF, Coric V. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder. J Affect Disord. 2010 Feb; 121(1-2):175-9. PMID: 19577308; PMCID: PMC3974618.
    71. Storch EA, Khanna M, Merlo LJ, Loew BA, Franklin M, Reid JM, Goodman WK, Murphy TK. Children's Florida Obsessive Compulsive Inventory: psychometric properties and feasibility of a self-report measure of obsessive-compulsive symptoms in youth. Child Psychiatry Hum Dev. 2009 Sep; 40(3):467-83. PMID: 19326209.
      View in: PubMed
    72. Lack CW, Storch EA, Keeley ML, Geffken GR, Ricketts ED, Murphy TK, Goodman WK. Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates. Soc Psychiatry Psychiatr Epidemiol. 2009 Nov; 44(11):935-42. PMID: 19255701.
      View in: PubMed
    73. Goodman WK, Insel TR. Deep brain stimulation in psychiatry: concentrating on the road ahead. Biol Psychiatry. 2009 Feb 15; 65(4):263-6. PMID: 19167964.
      View in: PubMed
    74. Goldstein RB, Storch EA, Lehmkuhl H, Geffken GR, Goodman WK, Murphy TK. Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder. Depress Anxiety. 2009; 26(1):E23-5. PMID: 19067320.
      View in: PubMed
    75. Burdick A, Goodman WK, Foote KD. Deep brain stimulation for refractory obsessive-compulsive disorder. Front Biosci (Landmark Ed). 2009 Jan 01; 14:1880-90. PMID: 19273170.
      View in: PubMed
    76. Sulkowski ML, Storch EA, Geffken GR, Ricketts E, Murphy TK, Goodman WK. Concurrent validity of the Yale-Brown Obsessive-Compulsive Scale-Symptom Checklist. J Clin Psychol. 2008 Dec; 64(12):1338-51. PMID: 18942133.
      View in: PubMed
    77. Wang PS, Heinssen R, Oliveri M, Wagner A, Goodman W. Bridging bench and practice: translational research for schizophrenia and other psychotic disorders. Neuropsychopharmacology. 2009 Jan; 34(1):204-12. PMID: 18830238.
      View in: PubMed
    78. Brady LS, Winsky L, Goodman W, Oliveri ME, Stover E. NIMH initiatives to facilitate collaborations among industry, academia, and government for the discovery and clinical testing of novel models and drugs for psychiatric disorders. Neuropsychopharmacology. 2009 Jan; 34(1):229-43. PMID: 18800066.
      View in: PubMed
    79. Stewart SE, Rosario MC, Baer L, Carter AS, Brown TA, Scharf JM, Illmann C, Leckman JF, Sukhodolsky D, Katsovich L, Rasmussen S, Goodman W, Delorme R, Leboyer M, Chabane N, Jenike MA, Geller DA, Pauls DL. Four-factor structure of obsessive-compulsive disorder symptoms in children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2008 Jul; 47(7):763-72. PMID: 18520961.
      View in: PubMed
    80. Storch EA, Milsom VA, Merlo LJ, Larson M, Geffken GR, Jacob ML, Murphy TK, Goodman WK. Insight in pediatric obsessive-compulsive disorder: associations with clinical presentation. Psychiatry Res. 2008 Aug 15; 160(2):212-20. PMID: 18556071.
      View in: PubMed
    81. Greenberg BD, Gabriels LA, Malone DA, Rezai AR, Friehs GM, Okun MS, Shapira NA, Foote KD, Cosyns PR, Kubu CS, Malloy PF, Salloway SP, Giftakis JE, Rise MT, Machado AG, Baker KB, Stypulkowski PH, Goodman WK, Rasmussen SA, Nuttin BJ. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry. 2010 Jan; 15(1):64-79. PMID: 18490925; PMCID: PMC3790898.
    82. Aldea MA, Geffken GR, Jacob ML, Goodman WK, Storch EA. Further psychometric analysis of the Florida Obsessive-Compulsive Inventory. J Anxiety Disord. 2009 Jan; 23(1):124-9. PMID: 18571371.
      View in: PubMed
    83. Storch EA, Merlo LJ, Larson MJ, Geffken GR, Lehmkuhl HD, Jacob ML, Murphy TK, Goodman WK. Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2008 May; 47(5):583-92. PMID: 18356759.
      View in: PubMed
    84. Murphy TK, Segarra A, Storch EA, Goodman WK. SSRI adverse events: how to monitor and manage. Int Rev Psychiatry. 2008 Apr; 20(2):203-8. PMID: 18386213.
      View in: PubMed
    85. Storch EA, McNamara J, Jordan C, Marien WE, Jacob ML, Murphy TK, Goodman WK, Geffken GR. Associations between miscellaneous symptoms and symptom dimensions in adults with obsessive-compulsive disorder. Anxiety Stress Coping. 2008 Apr; 21(2):199-212. PMID: 18350397.
      View in: PubMed
    86. George MS, Ward HE, Ninan PT, Pollack M, Nahas Z, Anderson B, Kose S, Howland RH, Goodman WK, Ballenger JC. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21. PMID: 20633378.
      View in: PubMed
    87. Gallant J, Storch EA, Merlo LJ, Ricketts ED, Geffken GR, Goodman WK, Murphy TK. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist. J Anxiety Disord. 2008 Dec; 22(8):1369-76. PMID: 18329843.
      View in: PubMed
    88. Okun MS, Fernandez HH, Foote KD, Murphy TK, Goodman WK. Avoiding deep brain stimulation failures in Tourette syndrome. J Neurol Neurosurg Psychiatry. 2008 Feb; 79(2):111-2. PMID: 18202200.
      View in: PubMed
    89. Storch EA, Abramowitz J, Goodman WK. Where does obsessive-compulsive disorder belong in DSM-V? Depress Anxiety. 2008; 25(4):336-47. PMID: 18412060.
      View in: PubMed
    90. Storch EA, Stigge-Kaufman D, Marien WE, Sajid M, Jacob ML, Geffken GR, Goodman WK, Murphy TK. Obsessive-compulsive disorder in youth with and without a chronic tic disorder. Depress Anxiety. 2008; 25(9):761-7. PMID: 17345600.
      View in: PubMed
    91. Storch EA, Merlo LJ, Lehmkuhl H, Geffken GR, Jacob M, Ricketts E, Murphy TK, Goodman WK. Cognitive-behavioral therapy for obsessive-compulsive disorder: a non-randomized comparison of intensive and weekly approaches. J Anxiety Disord. 2008 Oct; 22(7):1146-58. PMID: 18242950.
      View in: PubMed
    92. Goodman WK, Lydiard RB. Recognition and treatment of obsessive-compulsive disorder. J Clin Psychiatry. 2007 Dec; 68(12):e30. PMID: 18162010.
      View in: PubMed
    93. Storch EA, Merlo LJ, Larson MJ, Bloss CS, Geffken GR, Jacob ML, Murphy TK, Goodman WK. Symptom dimensions and cognitive-behavioural therapy outcome for pediatric obsessive-compulsive disorder. Acta Psychiatr Scand. 2008 Jan; 117(1):67-75. PMID: 17986317.
      View in: PubMed
    94. Storch EA, Murphy TK, Lack CW, Geffken GR, Jacob ML, Goodman WK. Sleep-related problems in pediatric obsessive-compulsive disorder. J Anxiety Disord. 2008 Jun; 22(5):877-85. PMID: 17951025.
      View in: PubMed
    95. Storch EA, Kaufman DA, Bagner D, Merlo LJ, Shapira NA, Geffken GR, Murphy TK, Goodman WK. Florida Obsessive-Compulsive Inventory: development, reliability, and validity. J Clin Psychol. 2007 Sep; 63(9):851-9. PMID: 17674398.
      View in: PubMed
    96. Storch EA, Merlo LJ, Larson MJ, Marien WE, Geffken GR, Jacob ML, Goodman WK, Murphy TK. Clinical features associated with treatment-resistant pediatric obsessive-compulsive disorder. Compr Psychiatry. 2008 Jan-Feb; 49(1):35-42. PMID: 18063039.
      View in: PubMed
    97. Storch EA, Merlo LJ, Bengtson M, Murphy TK, Lewis MH, Yang MC, Jacob ML, Larson M, Hirsh A, Fernandez M, Geffken GR, Goodman WK. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol. 2007 Jul; 22(4):230-7. PMID: 17519647.
      View in: PubMed
    98. Storch EA, Lack C, Merlo LJ, Marien WE, Geffken GR, Grabill K, Jacob ML, Murphy TK, Goodman WK. Associations between miscellaneous symptoms and symptom dimensions: an examination of pediatric obsessive-compulsive disorder. Behav Res Ther. 2007 Nov; 45(11):2593-603. PMID: 17644061.
      View in: PubMed
    99. Storch EA, Lack CW, Merlo LJ, Geffken GR, Jacob ML, Murphy TK, Goodman WK. Clinical features of children and adolescents with obsessive-compulsive disorder and hoarding symptoms. Compr Psychiatry. 2007 Jul-Aug; 48(4):313-8. PMID: 17560950.
      View in: PubMed
    100. Storch EA, Lack CW, Simons LE, Goodman WK, Murphy TK, Geffken GR. A measure of functional impairment in youth with Tourette's syndrome. J Pediatr Psychol. 2007 Sep; 32(8):950-9. PMID: 17522110.
      View in: PubMed
    101. Storch EA, Geffken GR, Merlo LJ, Jacob ML, Murphy TK, Goodman WK, Larson MJ, Fernandez M, Grabill K. Family accommodation in pediatric obsessive-compulsive disorder. J Clin Child Adolesc Psychol. 2007 Apr-Jun; 36(2):207-16. PMID: 17484693.
      View in: PubMed
    102. Storch EA, Merlo LJ, Lack C, Milsom VA, Geffken GR, Goodman WK, Murphy TK. Quality of life in youth with Tourette's syndrome and chronic tic disorder. J Clin Child Adolesc Psychol. 2007 Apr-Jun; 36(2):217-27. PMID: 17484694.
      View in: PubMed
    103. Storch EA, Geffken GR, Merlo LJ, Mann G, Duke D, Munson M, Adkins J, Grabill KM, Murphy TK, Goodman WK. Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry. 2007 Apr; 46(4):469-78. PMID: 17420681.
      View in: PubMed
    104. Storch EA, Bagner DM, Geffken GR, Adkins JW, Murphy TK, Goodman WK. Sequential cognitive-behavioral therapy for children with obsessive-compulsive disorder with an inadequate medication response: a case series of five patients. Depress Anxiety. 2007; 24(6):375-81. PMID: 17044015.
      View in: PubMed
    105. Goodman WK, Murphy TK, Storch EA. Risk of adverse behavioral effects with pediatric use of antidepressants. Psychopharmacology (Berl). 2007 Mar; 191(1):87-96. PMID: 17180618.
      View in: PubMed
    106. Storch EA, Murphy TK, Fernandez M, Krishnan M, Geffken GR, Kellgren AR, Goodman WK. Factor-analytic study of the Yale Global Tic Severity Scale. Psychiatry Res. 2007 Jan 15; 149(1-3):231-7. PMID: 17150256.
      View in: PubMed
    107. Storch EA, Merlo LJ, Lehmkuhl H, Grabill KM, Geffken GR, Goodman WK, Murphy TK. Further psychometric examination of the Tourette's Disorder Scales. Child Psychiatry Hum Dev. 2007 Aug; 38(2):89-98. PMID: 17136450.
      View in: PubMed
    108. Murphy TK, Snider LA, Mutch PJ, Harden E, Zaytoun A, Edge PJ, Storch EA, Yang MC, Mann G, Goodman WK, Swedo SE. Relationship of movements and behaviors to Group A Streptococcus infections in elementary school children. Biol Psychiatry. 2007 Feb 01; 61(3):279-84. PMID: 17126304.
      View in: PubMed
    109. Storch EA, Murphy TK, Geffken GR, Mann G, Adkins J, Merlo LJ, Duke D, Munson M, Swaine Z, Goodman WK. Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: findings from a preliminary waitlist controlled open trial. J Am Acad Child Adolesc Psychiatry. 2006 Oct; 45(10):1171-8. PMID: 17003662.
      View in: PubMed
    110. Okun MS, Mann G, Foote KD, Shapira NA, Bowers D, Springer U, Knight W, Martin P, Goodman WK. Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming. J Neurol Neurosurg Psychiatry. 2007 Mar; 78(3):310-4. PMID: 17012341; PMCID: PMC2117652.
    111. Storch EA, Ledley DR, Lewin AB, Murphy TK, Johns NB, Goodman WK, Geffken GR. Peer victimization in children with obsessive-compulsive disorder: relations with symptoms of psychopathology. J Clin Child Adolesc Psychol. 2006 Sep; 35(3):446-55. PMID: 16836482.
      View in: PubMed
    112. Olson LL, Singer HS, Goodman WK, Maria BL. Tourette syndrome: diagnosis, strategies, therapies, pathogenesis, and future research directions. J Child Neurol. 2006 Aug; 21(8):630-41. PMID: 16970863.
      View in: PubMed
    113. Goodman WK, Storch EA, Geffken GR, Murphy TK. Obsessive-compulsive disorder in Tourette syndrome. J Child Neurol. 2006 Aug; 21(8):704-14. PMID: 16970872.
      View in: PubMed
    114. Husted DS, Shapira NA, Murphy TK, Mann GD, Ward HE, Goodman WK. Effect of comorbid tics on a clinically meaningful response to 8-week open-label trial of fluoxetine in obsessive compulsive disorder. J Psychiatr Res. 2007 Apr-Jun; 41(3-4):332-7. PMID: 16860338.
      View in: PubMed
    115. Greenberg BD, Malone DA, Friehs GM, Rezai AR, Kubu CS, Malloy PF, Salloway SP, Okun MS, Goodman WK, Rasmussen SA. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 2006 Nov; 31(11):2384-93. PMID: 16855529.
      View in: PubMed
    116. Skidmore FM, Rodriguez RL, Fernandez HH, Goodman WK, Foote KD, Okun MS. Lessons learned in deep brain stimulation for movement and neuropsychiatric disorders. CNS Spectr. 2006 Jul; 11(7):521-36. PMID: 16816792.
      View in: PubMed
    117. Murphy TK, Sajid MW, Goodman WK. Immunology of obsessive-compulsive disorder. Psychiatr Clin North Am. 2006 Jun; 29(2):445-69. PMID: 16650717.
      View in: PubMed
    118. Springer US, Bowers D, Goodman WK, Shapira NA, Foote KD, Okun MS. Long-term habituation of the smile response with deep brain stimulation. Neurocase. 2006 Jun; 12(3):191-6. PMID: 16801154.
      View in: PubMed
    119. Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006 Jun; 69(11):1945-53. PMID: 16641930.
      View in: PubMed
    120. Hirsh A, O'Brien K, Geffken GR, Adkins J, Goodman WK, Storch EA. Cognitive-behavioral treatment for obsessive-compulsive disorder in an elderly male with concurrent medical constraints. Am J Geriatr Psychiatry. 2006 Apr; 14(4):380-1. PMID: 16582047.
      View in: PubMed
    121. Shapira NA, Okun MS, Wint D, Foote KD, Byars JA, Bowers D, Springer US, Lang PJ, Greenberg BD, Haber SN, Goodman WK. Panic and fear induced by deep brain stimulation. J Neurol Neurosurg Psychiatry. 2006 Mar; 77(3):410-2. PMID: 16484657; PMCID: PMC2077710.
    122. Lewin AB, Storch EA, Geffken GR, Goodman WK, Murphy TK. A neuropsychiatric review of pediatric obsessive-compulsive disorder: etiology and efficacious treatments. Neuropsychiatr Dis Treat. 2006 Mar; 2(1):21-31. PMID: 19412443; PMCID: PMC2671737.
    123. Storch EA, Murphy TK, Adkins JW, Lewin AB, Geffken GR, Johns NB, Jann KE, Goodman WK. The children's Yale-Brown obsessive-compulsive scale: psychometric properties of child- and parent-report formats. J Anxiety Disord. 2006; 20(8):1055-70. PMID: 16503111.
      View in: PubMed
    124. Husted DS, Shapira NA, Goodman WK. The neurocircuitry of obsessive-compulsive disorder and disgust. Prog Neuropsychopharmacol Biol Psychiatry. 2006 May; 30(3):389-99. PMID: 16443315.
      View in: PubMed
    125. Storch EA, Larson MJ, Shapira NA, Ward HE, Murphy TK, Geffken GR, Valerio H, Goodman WK. Clinical predictors of early fluoxetine treatment response in obsessive-compulsive disorder. Depress Anxiety. 2006; 23(7):429-33. PMID: 16841343.
      View in: PubMed
    126. Storch EA, Murphy TK, Geffken GR, Sajid M, Allen P, Roberti JW, Goodman WK. Reliability and validity of the Yale Global Tic Severity Scale. Psychol Assess. 2005 Dec; 17(4):486-91. PMID: 16393016.
      View in: PubMed
    127. Geffken GR, Storch EA, Duke DC, Monaco L, Lewin AB, Goodman WK. Hope and coping in family members of patients with obsessive-compulsive disorder. J Anxiety Disord. 2006; 20(5):614-29. PMID: 16084686.
      View in: PubMed
    128. Goodman WK, Bose A, Wang Q. Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials. J Affect Disord. 2005 Aug; 87(2-3):161-7. PMID: 15982747.
      View in: PubMed
    129. Storch EA, Murphy TK, Bagner DM, Johns NB, Baumeister AL, Goodman WK, Geffken GR. Reliability and validity of the Child Behavior Checklist Obsessive-Compulsive Scale. J Anxiety Disord. 2006; 20(4):473-85. PMID: 16046257.
      View in: PubMed
    130. Byerly M, Goodman W, Acholonu W, Bugno R, Rush AJ. Obsessive compulsive symptoms in schizophrenia: frequency and clinical features. Schizophr Res. 2005 Jul 15; 76(2-3):309-16. PMID: 15949663.
      View in: PubMed
    131. Storch EA, Murphy TK, Geffken GR, Bagner DM, Soto O, Sajid M, Allen P, Killiany EM, Goodman WK. Factor analytic study of the Children's Yale-Brown Obsessive-Compulsive Scale. J Clin Child Adolesc Psychol. 2005 Jun; 34(2):312-9. PMID: 15901231.
      View in: PubMed
    132. Stein DJ, Andersen HF, Goodman WK. Escitalopram for the treatment of GAD: efficacy across different subgroups and outcomes. Ann Clin Psychiatry. 2005 Apr-Jun; 17(2):71-5. PMID: 16075659.
      View in: PubMed
    133. Storch EA, Shapira NA, Dimoulas E, Geffken GR, Murphy TK, Goodman WK. Yale-Brown Obsessive Compulsive Scale: the dimensional structure revisited. Depress Anxiety. 2005; 22(1):28-35. PMID: 16130118.
      View in: PubMed
    134. Merlo LJ, Storch EA, Murphy TK, Goodman WK, Geffken GR. Assessment of pediatric obsessive-compulsive disorder: a critical review of current methodology. Child Psychiatry Hum Dev. 2005; 36(2):195-214. PMID: 16228147.
      View in: PubMed
    135. Geffken GR, Storch EA, Gelfand KM, Adkins JW, Goodman WK. Cognitive-behavioral therapy for obsessive-compulsive disorder: review of treatment techniques. J Psychosoc Nurs Ment Health Serv. 2004 Dec; 42(12):44-51. PMID: 15633304.
      View in: PubMed
    136. Storch EA, Murphy TK, Geffken GR, Soto O, Sajid M, Allen P, Roberti JW, Killiany EM, Goodman WK. Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale. Psychiatry Res. 2004 Nov 30; 129(1):91-8. PMID: 15572188.
      View in: PubMed
    137. Wright P, He G, Shapira NA, Goodman WK, Liu Y. Disgust and the insula: fMRI responses to pictures of mutilation and contamination. Neuroreport. 2004 Oct 25; 15(15):2347-51. PMID: 15640753.
      View in: PubMed
    138. Okun MS, Bowers D, Springer U, Shapira NA, Malone D, Rezai AR, Nuttin B, Heilman KM, Morecraft RJ, Rasmussen SA, Greenberg BD, Foote KD, Goodman WK. What's in a "smile?" Intra-operative observations of contralateral smiles induced by deep brain stimulation. Neurocase. 2004 Aug; 10(4):271-9. PMID: 15788264.
      View in: PubMed
    139. Shapira NA, Lessig MC, Lewis MH, Goodman WK, Driscoll DJ. Effects of topiramate in adults with Prader-Willi syndrome. Am J Ment Retard. 2004 Jul; 109(4):301-9. PMID: 15176917.
      View in: PubMed
    140. Culpepper L, Davidson JR, Dietrich AJ, Goodman WK, Kroenke K, Schwenk TL. Suicidality as a possible side effect of antidepressant treatment. J Clin Psychiatry. 2004 Jun; 65(6):742-9. PMID: 15291649.
      View in: PubMed
    141. Shapira NA, Ward HE, Mandoki M, Murphy TK, Yang MC, Blier P, Goodman WK. A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder. Biol Psychiatry. 2004 Mar 01; 55(5):553-5. PMID: 15023585.
      View in: PubMed
    142. Murphy TK, Sajid M, Soto O, Shapira N, Edge P, Yang M, Lewis MH, Goodman WK. Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics. Biol Psychiatry. 2004 Jan 01; 55(1):61-8. PMID: 14706426.
      View in: PubMed
    143. Culpepper L, Davidson JR, Dietrich AJ, Goodman WK, Kroenke K, Schwenk TL. Suicidality as a Possible Side Effect of Antidepressant Treatment. Prim Care Companion J Clin Psychiatry. 2004; 6(2):79-86. PMID: 15254601.
      View in: PubMed
    144. Goodman WK. Selecting pharmacotherapy for generalized anxiety disorder. J Clin Psychiatry. 2004; 65 Suppl 13:8-13. PMID: 15384931.
      View in: PubMed
    145. Storch EA, Murphy TK, Geffken GR, Soto O, Sajid M, Allen P, Roberti JW, Killiany EM, Goodman WK. Further psychometric properties of the Tourette's Disorder Scale-Parent Rated version (TODS-PR). Child Psychiatry Hum Dev. 2004; 35(2):107-20. PMID: 15577277.
      View in: PubMed
    146. Pallanti S, Hollander E, Goodman WK. A qualitative analysis of nonresponse: management of treatment-refractory obsessive-compulsive disorder. J Clin Psychiatry. 2004; 65 Suppl 14:6-10. PMID: 15554782.
      View in: PubMed
    147. Shapira NA, Liu Y, He AG, Bradley MM, Lessig MC, James GA, Stein DJ, Lang PJ, Goodman WK. Brain activation by disgust-inducing pictures in obsessive-compulsive disorder. Biol Psychiatry. 2003 Oct 01; 54(7):751-6. PMID: 14512216.
      View in: PubMed
    148. Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM. A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder. J Clin Psychiatry. 2003 Jun; 64(6):640-7. PMID: 12823077.
      View in: PubMed
    149. Nadeau SE, McCoy KJ, Crucian GP, Greer RA, Rossi F, Bowers D, Goodman WK, Heilman KM, Triggs WJ. Cerebral blood flow changes in depressed patients after treatment with repetitive transcranial magnetic stimulation: evidence of individual variability. Neuropsychiatry Neuropsychol Behav Neurol. 2002 Sep; 15(3):159-75. PMID: 12218709.
      View in: PubMed
    150. Shapira NA, Lessig MC, Murphy TK, Driscoll DJ, Goodman WK. Topiramate attenuates self-injurious behaviour in Prader-Willi Syndrome. Int J Neuropsychopharmacol. 2002 Jun; 5(2):141-5. PMID: 12135538.
      View in: PubMed
    151. Mataix-Cols D, Rauch SL, Baer L, Eisen JL, Shera DM, Goodman WK, Rasmussen SA, Jenike MA. Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study. Am J Psychiatry. 2002 Feb; 159(2):263-8. PMID: 11823269.
      View in: PubMed
    152. Murphy T, Goodman W. Genetics of childhood disorders: XXXIV. Autoimmune disorders, part 7: D8/17 reactivity as an immunological marker of susceptibility to neuropsychiatric disorders. J Am Acad Child Adolesc Psychiatry. 2002 Jan; 41(1):98-100. PMID: 11800215.
      View in: PubMed
    153. Murphy TK, Benson N, Zaytoun A, Yang M, Braylan R, Ayoub E, Goodman WK. Progress toward analysis of D8/17 binding to B cells in children with obsessive compulsive disorder and/or chronic tic disorder. J Neuroimmunol. 2001 Nov 01; 120(1-2):146-51. PMID: 11694329.
      View in: PubMed
    154. Murphy TK, Petitto JM, Voeller KK, Goodman WK. Obsessive compulsive disorder: is there an association with childhood streptococcal infections and altered immune function? Semin Clin Neuropsychiatry. 2001 Oct; 6(4):266-76. PMID: 11607922.
      View in: PubMed
    155. Stein DJ, Liu Y, Shapira NA, Goodman WK. The psychobiology of obsessive-compulsive disorder: how important is the role of disgust? Curr Psychiatry Rep. 2001 Aug; 3(4):281-7. PMID: 11470034.
      View in: PubMed
    156. Narasimhan LR, Goodman W, Patel CK. Correlation of breath ammonia with blood urea nitrogen and creatinine during hemodialysis. Proc Natl Acad Sci U S A. 2001 Apr 10; 98(8):4617-21. PMID: 11296293; PMCID: PMC31883.
    157. Romano S, Goodman W, Tamura R, Gonzales J. Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo. J Clin Psychopharmacol. 2001 Feb; 21(1):46-52. PMID: 11199947.
      View in: PubMed
    158. Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL. Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res. 2001 Jan; 16(1):182-8. PMID: 11149483.
      View in: PubMed
    159. Stein DJ, Goodman WK, Rauch SL. The cognitive-affective neuroscience of obsessive-compulsive disorder. Curr Psychiatry Rep. 2000 Aug; 2(4):341-6. PMID: 11122979.
      View in: PubMed
    160. Murphy TK, Goodman WK, Ayoub EM, Voeller KK. On defining Sydenham's chorea: where do we draw the line? Biol Psychiatry. 2000 May 15; 47(10):851-7. PMID: 10807957.
      View in: PubMed
    161. Morris MR, Forbes S, Bradley MM, Goodman WK. Stability of subclinical obsessive compulsive disorder in college students. Depress Anxiety. 2000; 11(4):180-2. PMID: 10945139.
      View in: PubMed
    162. Alsobrook II JP, Leckman JF, Goodman WK, Rasmussen SA, Pauls DL. Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. Am J Med Genet. 1999 Dec 15; 88(6):669-75. PMID: 10581488.
      View in: PubMed
    163. van Wattum PJ, Anderson GM, Chappell PB, Goodman WK, Riddle MA, Leckman JF. Cerebrospinal fluid dynorphin A[1-8] and beta-endorphin levels in Tourette's syndrome are unaltered. Biol Psychiatry. 1999 Jun 01; 45(11):1527-8. PMID: 10356639.
      View in: PubMed
    164. Triggs WJ, McCoy KJ, Greer R, Rossi F, Bowers D, Kortenkamp S, Nadeau SE, Heilman KM, Goodman WK. Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor threshold. Biol Psychiatry. 1999 Jun 01; 45(11):1440-6. PMID: 10356626.
      View in: PubMed
    165. Eisen JL, Goodman WK, Keller MB, Warshaw MG, DeMarco LM, Luce DD, Rasmussen SA. Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study. J Clin Psychiatry. 1999 May; 60(5):346-51; quiz 352. PMID: 10362449.
      View in: PubMed
    166. Goddard AW, Woods SW, Money R, Pande AC, Charney DS, Goodman WK, Heninger GR, Price LH. Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorder. Psychiatry Res. 1999 Mar 22; 85(3):225-40. PMID: 10333376.
      View in: PubMed
    167. Goodman WK. Obsessive-compulsive disorder: diagnosis and treatment. J Clin Psychiatry. 1999; 60 Suppl 18:27-32. PMID: 10487253.
      View in: PubMed
    168. McDougle CJ, Barr LC, Goodman WK, Price LH. Possible role of neuropeptides in obsessive compulsive disorder. Psychoneuroendocrinology. 1999 Jan; 24(1):1-24. PMID: 10098217.
      View in: PubMed
    169. Barr LC, Goodman WK, Anand A, McDougle CJ, Price LH. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder. Am J Psychiatry. 1997 Sep; 154(9):1293-5. PMID: 9286191.
      View in: PubMed
    170. Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, Alsobrook J, Peterson BS, Cohen DJ, Rasmussen SA, Goodman WK, McDougle CJ, Pauls DL. Symptoms of obsessive-compulsive disorder. Am J Psychiatry. 1997 Jul; 154(7):911-7. PMID: 9210740.
      View in: PubMed
    171. Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, Cicchetti D, Leckman JF. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997 Jun; 36(6):844-52. PMID: 9183141.
      View in: PubMed
    172. Barr LC, Heninger GR, Goodman W, Charney DS, Price LH. Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects. Biol Psychiatry. 1997 May 01; 41(9):949-54. PMID: 9110100.
      View in: PubMed
    173. Murphy TK, Goodman WK, Fudge MW, Williams RC, Ayoub EM, Dalal M, Lewis MH, Zabriskie JB. B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome? Am J Psychiatry. 1997 Mar; 154(3):402-7. PMID: 9054790.
      View in: PubMed
    174. Rasmusson AM, Anderson GM, Lynch KA, McSwiggan-Hardin M, Scahill LD, Mazure CM, Goodman WK, Price LH, Cohen DJ, Leckman JF. A preliminary study of tryptophan depletion on tics, obsessive-compulsive symptoms, and mood in Tourette's syndrome. Biol Psychiatry. 1997 Jan 01; 41(1):117-21. PMID: 8988803.
      View in: PubMed
    175. Phillips KA, Hollander E, Rasmussen SA, Aronowitz BR, DeCaria C, Goodman WK. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull. 1997; 33(1):17-22. PMID: 9133747.
      View in: PubMed
    176. Goodman WK, Ward H, Kablinger A, Murphy T. Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions. J Clin Psychiatry. 1997; 58 Suppl 5:32-49. PMID: 9184625.
      View in: PubMed
    177. Bernstein CN, Seeger LL, Anton PA, Artinian L, Geffrey S, Goodman W, Belin TR, Shanahan F. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther. 1996 Oct; 10(5):777-86. PMID: 8899087.
      View in: PubMed
    178. Jenike MA, Rauch SL, Cummings JL, Savage CR, Goodman WK. Recent developments in neurobiology of obsessive-compulsive disorder. J Clin Psychiatry. 1996 Oct; 57(10):492-503. PMID: 8909341.
      View in: PubMed
    179. Byerly MJ, Goodman WK, Christensen R. High doses of sertraline for treatment-resistant obsessive-compulsive disorder. Am J Psychiatry. 1996 Sep; 153(9):1232-3. PMID: 8780435.
      View in: PubMed
    180. Chappell P, Leckman J, Goodman W, Bissette G, Pauls D, Anderson G, Riddle M, Scahill L, McDougle C, Cohen D. Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive compulsive disorder and normal controls. Biol Psychiatry. 1996 May 01; 39(9):776-83. PMID: 8731518.
      View in: PubMed
    181. Goodman WK, Kozak MJ, Liebowitz M, White KL. Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial. Int Clin Psychopharmacol. 1996 Mar; 11(1):21-9. PMID: 8732310.
      View in: PubMed
    182. Morris MR, Blashfield RK, Rankupalli B, Bradley MM, Goodman WK. Subclinical obsessive-compulsive disorder in college students. Depress Anxiety. 1996-1997; 4(5):233-6. PMID: 9167789.
      View in: PubMed
    183. McDougle CJ, Barr LC, Goodman WK, Pelton GH, Aronson SC, Anand A, Price LH. Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder. Am J Psychiatry. 1995 Dec; 152(12):1812-4. PMID: 8526253.
      View in: PubMed
    184. Goodman WK, McDougle CJ, Price LH, Barr LC, Hills OF, Caplik JF, Charney DS, Heninger GR. m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation. Biol Psychiatry. 1995 Aug 01; 38(3):138-49. PMID: 7578657.
      View in: PubMed
    185. Goddard AW, Charney DS, Germine M, Woods SW, Heninger GR, Krystal JH, Goodman WK, Price LH. Effects of tryptophan depletion on responses to yohimbine in healthy human subjects. Biol Psychiatry. 1995 Jul 15; 38(2):74-85. PMID: 7578653.
      View in: PubMed
    186. McDougle CJ, Kresch LE, Goodman WK, Naylor ST, Volkmar FR, Cohen DJ, Price LH. A case-controlled study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. Am J Psychiatry. 1995 May; 152(5):772-7. PMID: 7726318.
      View in: PubMed
    187. Calvocoressi L, Lewis B, Harris M, Trufan SJ, Goodman WK, McDougle CJ, Price LH. Family accommodation in obsessive-compulsive disorder. Am J Psychiatry. 1995 Mar; 152(3):441-3. PMID: 7864273.
      View in: PubMed
    188. Leckman JF, Goodman WK, Anderson GM, Riddle MA, Chappell PB, McSwiggan-Hardin MT, McDougle CJ, Scahill LD, Ort SI, Pauls DL, et al. Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology. 1995 Feb; 12(1):73-86. PMID: 7766289.
      View in: PubMed
    189. Pauls DL, Alsobrook JP, Goodman W, Rasmussen S, Leckman JF. A family study of obsessive-compulsive disorder. Am J Psychiatry. 1995 Jan; 152(1):76-84. PMID: 7802125.
      View in: PubMed
    190. Foa EB, Kozak MJ, Goodman WK, Hollander E, Jenike MA, Rasmussen SA. DSM-IV field trial: obsessive-compulsive disorder. Am J Psychiatry. 1995 Jan; 152(1):90-6. PMID: 7802127.
      View in: PubMed
    191. Goddard AW, Sholomskas DE, Walton KE, Augeri FM, Charney DS, Heninger GR, Goodman WK, Price LH. Effects of tryptophan depletion in panic disorder. Biol Psychiatry. 1994 Dec 01; 36(11):775-7. PMID: 7858076.
      View in: PubMed
    192. Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McSwiggan-Hardin M, McDougle CJ, et al. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls. Arch Gen Psychiatry. 1994 Oct; 51(10):782-92. PMID: 7524462.
      View in: PubMed
    193. Tollefson GD, Rampey AH, Potvin JH, Jenike MA, Rush AJ, kominguez RA, Koran LM, Shear MK, Goodman W, Genduso LA. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1994 Jul; 51(7):559-67. PMID: 8031229.
      View in: PubMed
    194. Leckman JF, Walker DE, Goodman WK, Pauls DL, Cohen DJ. "Just right" perceptions associated with compulsive behavior in Tourette's syndrome. Am J Psychiatry. 1994 May; 151(5):675-80. PMID: 8166308.
      View in: PubMed
    195. McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry. 1994 Apr; 51(4):302-8. PMID: 8161290.
      View in: PubMed
    196. Barr LC, Goodman WK, McDougle CJ, Delgado PL, Heninger GR, Charney DS, Price LH. Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. Arch Gen Psychiatry. 1994 Apr; 51(4):309-17. PMID: 8161291.
      View in: PubMed
    197. Holzer JC, Goodman WK, McDougle CJ, Baer L, Boyarsky BK, Leckman JF, Price LH. Obsessive-compulsive disorder with and without a chronic tic disorder. A comparison of symptoms in 70 patients. Br J Psychiatry. 1994 Apr; 164(4):469-73. PMID: 8038934.
      View in: PubMed
    198. McDougle CJ, Goodman WK, Price LH. Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. J Clin Psychiatry. 1994 Mar; 55 Suppl:24-31. PMID: 7521326.
      View in: PubMed
    199. Barr LC, Goodman WK, Price LH. Physical symptoms associated with paroxetine discontinuation. Am J Psychiatry. 1994 Feb; 151(2):289. PMID: 8296907.
      View in: PubMed
    200. Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McDougle CJ, Barr LC, et al. The role of central oxytocin in obsessive compulsive disorder and related normal behavior. Psychoneuroendocrinology. 1994; 19(8):723-49. PMID: 7991761.
      View in: PubMed
    201. Leckman JF, Grice DE, Barr LC, de Vries AL, Martin C, Cohen DJ, McDougle CJ, Goodman WK, Rasmussen SA. Tic-related vs. non-tic-related obsessive compulsive disorder. Anxiety. 1994-1995; 1(5):208-15. PMID: 9160576.
      View in: PubMed
    202. Calvocoressi L, McDougle CI, Wasylink S, Goodman WK, Trufan SJ, Price LH. Inpatient treatment of patients with severe obsessive-compulsive disorder. Hosp Community Psychiatry. 1993 Dec; 44(12):1150-4. PMID: 8132187.
      View in: PubMed
    203. McDougle CJ, Goodman WK, Leckman JF, Price LH. The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis. Psychiatr Clin North Am. 1993 Dec; 16(4):749-66. PMID: 8309811.
      View in: PubMed
    204. Barr LC, Goodman WK, Price LH. The serotonin hypothesis of obsessive compulsive disorder. Int Clin Psychopharmacol. 1993 Nov; 8 Suppl 2:79-82. PMID: 8201248.
      View in: PubMed
    205. McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. J Clin Psychopharmacol. 1993 Oct; 13(5):354-8. PMID: 8227493.
      View in: PubMed
    206. Goddard AW, Woods SW, Sholomskas DE, Goodman WK, Charney DS, Heninger GR. Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder. Psychiatry Res. 1993 Aug; 48(2):119-33. PMID: 8416022.
      View in: PubMed
    207. Goodman WK, McDougle CJ, Barr LC, Aronson SC, Price LH. Biological approaches to treatment-resistant obsessive compulsive disorder. J Clin Psychiatry. 1993 Jun; 54 Suppl:16-26. PMID: 8331098.
      View in: PubMed
    208. McDougle CJ, Goodman WK, Price LH. The pharmacotherapy of obsessive-compulsive disorder. Pharmacopsychiatry. 1993 May; 26 Suppl 1:24-9. PMID: 8378419.
      View in: PubMed
    209. McDougle CJ, Naylor ST, Goodman WK, Volkmar FR, Cohen DJ, Price LH. Acute tryptophan depletion in autistic disorder: a controlled case study. Biol Psychiatry. 1993 Apr 01; 33(7):547-50. PMID: 8513041.
      View in: PubMed
    210. McDougle CJ, Goodman WK, Leckman JF, Holzer JC, Barr LC, McCance-Katz E, Heninger GR, Price LH. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry. 1993 Apr; 150(4):647-9. PMID: 8465885.
      View in: PubMed
    211. Rotter M, Goodman W. The relationship between insight and control in obsessive-compulsive disorder: implications for the insanity defense. Bull Am Acad Psychiatry Law. 1993; 21(2):245-52. PMID: 8364240.
      View in: PubMed
    212. Goodman WK, Price LH. Assessment of severity and change in obsessive compulsive disorder. Psychiatr Clin North Am. 1992 Dec; 15(4):861-9. PMID: 1461801.
      View in: PubMed
    213. Barr LC, Goodman WK, Price LH. Acute exacerbation of body dysmorphic disorder during tryptophan depletion. Am J Psychiatry. 1992 Oct; 149(10):1406-7. PMID: 1388335.
      View in: PubMed
    214. McDougle CJ, Price LH, Volkmar FR, Goodman WK, Ward-O'Brien D, Nielsen J, Bregman J, Cohen DJ. Clomipramine in autism: preliminary evidence of efficacy. J Am Acad Child Adolesc Psychiatry. 1992 Jul; 31(4):746-50. PMID: 1644740.
      View in: PubMed
    215. Goodman WK, McDougle CJ, Price LH. The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder. Int Clin Psychopharmacol. 1992 Jun; 7 Suppl 1:35-8. PMID: 1517555.
      View in: PubMed
    216. Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. J Clin Psychiatry. 1992 Apr; 53 Suppl:17-28. PMID: 1532961.
      View in: PubMed
    217. Goodman WK, McDougle CJ, Price LH. Pharmacotherapy of obsessive compulsive disorder. J Clin Psychiatry. 1992 Apr; 53 Suppl:29-37. PMID: 1532962.
      View in: PubMed
    218. King RA, Riddle MA, Goodman WK. Psychopharmacology of obsessive-compulsive disorder in Tourette syndrome. Adv Neurol. 1992; 58:283-91. PMID: 1414634.
      View in: PubMed
    219. Boyarsky BK, Perone LA, Lee NC, Goodman WK. Current treatment approaches to obsessive-compulsive disorder. Arch Psychiatr Nurs. 1991 Oct; 5(5):299-306. PMID: 1750780.
      View in: PubMed
    220. McDougle CJ, Price LH, Goodman WK, Charney DS, Heninger GR. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy. J Clin Psychopharmacol. 1991 Jun; 11(3):175-84. PMID: 1820757.
      View in: PubMed
    221. Wexler BE, Goodman WK. Cerebral laterality, perception of emotion, and treatment response in obsessive-compulsive disorder. Biol Psychiatry. 1991 May 01; 29(9):900-8. PMID: 2049488.
      View in: PubMed
    222. McDougle CJ, Price LH, Goodman WK. Fluvoxamine treatment of coincident autistic disorder and obsessive-compulsive disorder: a case report. J Autism Dev Disord. 1990 Dec; 20(4):537-43. PMID: 2126264.
      View in: PubMed
    223. Delgado PL, Goodman WK, Price LH, Heninger GR, Charney DS. Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder. Br J Psychiatry. 1990 Nov; 157:762-5. PMID: 2126219.
      View in: PubMed
    224. Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls DL, Leckman JF. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? J Clin Psychiatry. 1990 Aug; 51 Suppl:36-43; discussion 55-8. PMID: 2199433.
      View in: PubMed
    225. Leckman JF, Goodman WK, Riddle MA, Hardin MT, Anderson GM. Low CSF 5HIAA and obsessions of violence: report of two cases. Psychiatry Res. 1990 Jul; 33(1):95-9. PMID: 1699245.
      View in: PubMed
    226. Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Arch Gen Psychiatry. 1990 Jun; 47(6):577-85. PMID: 2112374.
      View in: PubMed
    227. McDougle CJ, Goodman WK, Price LH, Delgado PL, Krystal JH, Charney DS, Heninger GR. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry. 1990 May; 147(5):652-4. PMID: 1970224.
      View in: PubMed
    228. Price LH, Charney DS, Delgado PL, Goodman WK, Krystal JH, Woods SW, Heninger GR. Clinical data on the role of serotonin in the mechanism(s) of action of antidepressant drugs. J Clin Psychiatry. 1990 Apr; 51 Suppl:44-50; discussion 51-2. PMID: 2182616.
      View in: PubMed
    229. Hanrahan J, Goodman W, Rapagna S. Preparing mentally retarded students for mainstreaming: priorities of regular class and special school teachers. Am J Ment Retard. 1990 Mar; 94(5):470-4. PMID: 2317339.
      View in: PubMed
    230. DeVeaugh-Geiss J, Katz R, Landau P, Goodman W, Rasmussen S. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine. Psychopharmacol Bull. 1990; 26(1):54-9. PMID: 2196627.
      View in: PubMed
    231. Price LH, Charney DS, Delgado PL, Goodman WK, Krystal JH, Woods SW, Heninger GR. Clinical studies of 5-HT function using i.v. L-tryptophan. Prog Neuropsychopharmacol Biol Psychiatry. 1990; 14(4):459-72. PMID: 2236580.
      View in: PubMed
    232. Chouinard G, Goodman W, Greist J, Jenike M, Rasmussen S, White K, Hackett E, Gaffney M, Bick PA. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacol Bull. 1990; 26(3):279-84. PMID: 2274626.
      View in: PubMed
    233. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry. 1989 Nov; 46(11):1012-6. PMID: 2510699.
      View in: PubMed
    234. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989 Nov; 46(11):1006-11. PMID: 2684084.
      View in: PubMed
    235. McDougle CJ, Goodman WK, Delgado PL, Price LH. Pathophysiology of obsessive-compulsive disorder. Am J Psychiatry. 1989 Oct; 146(10):1350-1. PMID: 2782483.
      View in: PubMed
    236. Heninger GR, Charney DS, Price LH, Delgado P, Woods S, Goodman W. Effects of serotonergic agonists on neuroendocrine responses of rhesus monkeys and patients with depression and anxiety disorders. Psychopharmacol Ser. 1989; 7:94-104. PMID: 2687871.
      View in: PubMed
    237. Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Arch Gen Psychiatry. 1989 Jan; 46(1):36-44. PMID: 2491940.
      View in: PubMed
    238. Goodman WK, Price LH, Rasmussen SA, Heninger GR, Charney DS. Fluvoxamine as an antiobsessional agent. Psychopharmacol Bull. 1989; 25(1):31-5. PMID: 2505302.
      View in: PubMed
    239. Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry. 1988 Feb; 45(2):177-85. PMID: 3337615.
      View in: PubMed
    240. Woods SW, Charney DS, Goodman WK, Heninger GR. Carbon dioxide-induced anxiety. Behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects. Arch Gen Psychiatry. 1988 Jan; 45(1):43-52. PMID: 3122696.
      View in: PubMed
    241. Leckman JF, Riddle MA, Berrettini WH, Anderson GM, Hardin M, Chappell P, Bissette G, Nemeroff CB, Goodman WK, Cohen DJ. Elevated CSF dynorphin A [1-8] in Tourette's syndrome. Life Sci. 1988; 43(24):2015-23. PMID: 2463450.
      View in: PubMed
    242. Charney DS, Woods SW, Goodman WK, Heninger GR. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry. 1987 Aug; 144(8):1030-6. PMID: 3037926.
      View in: PubMed
    243. Price LH, Goodman WK, Charney DS, Rasmussen SA, Heninger GR. Treatment of severe obsessive-compulsive disorder with fluvoxamine. Am J Psychiatry. 1987 Aug; 144(8):1059-61. PMID: 3111279.
      View in: PubMed
    244. Goodman WK, Charney DS. A case of alprazolam, but not lorazepam, inducing manic symptoms. J Clin Psychiatry. 1987 Mar; 48(3):117-8. PMID: 3818553.
      View in: PubMed
    245. Charney DS, Woods SW, Goodman WK, Heninger GR. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology (Berl). 1987; 92(1):14-24. PMID: 3110824.
      View in: PubMed
    246. Rasmussen SA, Goodman WK, Woods SW, Heninger GR, Charney DS. Effects of yohimbine in obsessive compulsive disorder. Psychopharmacology (Berl). 1987; 93(3):308-13. PMID: 2829264.
      View in: PubMed
    247. Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, Quadrino LM, Heninger GR. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone. J Clin Psychiatry. 1986 Dec; 47(12):580-6. PMID: 3536889.
      View in: PubMed
    248. Woods SW, Charney DS, Loke J, Goodman WK, Redmond DE, Heninger GR. Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment. Arch Gen Psychiatry. 1986 Sep; 43(9):900-9. PMID: 3092780.
      View in: PubMed
    249. Goodman WK, Charney DS, Price LH, Woods SW, Heninger GR. Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases. Am J Psychiatry. 1986 Jul; 143(7):900-3. PMID: 2872826.
      View in: PubMed
    250. Goodman WK, Charney DS. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs. J Clin Psychiatry. 1985 Oct; 46(10 Pt 2):6-24. PMID: 3900056.
      View in: PubMed
    251. Pollack M, Woerner MG, Goodman W, Greenberg IM. Childhood development patterns of hospitalized adult schizophrenic and nonschizophrenic patients and their siblings. Am J Orthopsychiatry. 1966 Apr; 36(3):510-7. PMID: 5910516.
      View in: PubMed
    GOODMAN's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description